Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
2018 · ESMO Open · 105 citations
https://doi.org/10.1136/esmoopen-2018-000398
A
Amélie Dendooven
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
125
Papers
1.6K
Citations
21
h-index
38
i10-index
Amélie Dendooven is an academic researcher from University of Antwerp. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Chronic Kidney Disease and Diabetes & Amyloidosis: Diagnosis, Treatment, Outcomes. The author has an h-index of 21, co-authored 107 publications.
ORCID: 0000-0002-9900-7952Papers by this author
worksOrgan-specific genome diversity of replication-competent SARS-CoV-2
2021 · Nature Communications · 76 citations
https://doi.org/10.1038/s41467-021-26884-7
Obstacles and drivers in the adoption of Standardized Structured Reporting (SSR): insights from pathologists
2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 6 citations
https://doi.org/10.1007/s00428-024-04012-2
Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paper
2025 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 4 citations
https://doi.org/10.1007/s00428-025-04291-3
Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders
2022 · Clinical Kidney Journal · 3 citations
https://doi.org/10.1093/ckj/sfac208
Clinicopathological characteristics and disease chronicity in native kidney biopsies in Flanders
2022 · Clinical Kidney Journal · 3 citations
https://doi.org/10.1093/ckj/sfac208
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat